Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.
Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression. Clin Cancer Res. 2000 Oct; 6(10):4043-8.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents, Phytogenic
Breast Neoplasms
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Humans
Immunohistochemistry
Middle Aged
Paclitaxel
Proto-Oncogene Proteins c-bcl-2
Time Factors
authors with profiles
Suzanne D. Conzen
Olufunmilayo Olopade
Theodore Karrison
Gini Fleming